138
Participants
Start Date
February 16, 2024
Primary Completion Date
August 1, 2025
Study Completion Date
August 1, 2025
Mepivacaine
Patients will be administered a standard dose of mepivacaine 1.5% (4.5ml, 67.5mg) for total knee arthroplasty prior to surgery
Bupivacaine
Patients will be administered a standard dose of 0.75% hyperbaric bupivacaine (1.4ml, 10.5mg) for total knee arthroplasty prior to surgery
Prisma Health Patewood Hospital, Greenville
Prisma Health-Upstate
OTHER